Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (28)
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
1998 • 9,382 citations
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
1997 • 2,989 citations
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
1997 • 2,670 citations
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia
1997 • 2,154 citations
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
1997 • 2,011 citations
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
1997 • 1,912 citations
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
1997 • 1,911 citations
Early establishment of a pool of latently infected, resting CD4 + T cells during primary HIV-1 infection
1998 • 811 citations
Antigen-independent activation of naive and memory resting T cells by a cytokine combination.
1994 • 541 citations
Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary Study
1995 • 430 citations
Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus
1996 • 406 citations
Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines
1998 • 356 citations
Cellular and Anatomical Reservoirs of HIV-1 in Patients Receiving Potent Antiretroviral Combination Therapy
1998 • 310 citations
CONTROLLED TRIAL OF INTERLEUKIN-2 INFUSIONS IN PATIENTS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS
1996 • 214 citations
Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein.
1987 • 179 citations
Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity.
1996 • 168 citations
Subcutaneous Administration of Interleukin‐2 in Human Immunodeficiency Virus Type 1—Infected Persons
1997 • 164 citations
Toward HIV Eradication or Remission: The Tasks Ahead
1998 • 162 citations
Dilution assay statistics
1994 • 136 citations
Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment
1997 • 105 citations
Outpatient Continuous Intravenous Interleukin‐2 or Subcutaneous, Polyethylene Glycol‐Modified Interleukin‐2 in Human Immunodeficiency Virus‐Infected Patients: A Randomized, Controlled, Multicenter Study
1998 • 92 citations
Rapid Cytokine Release in Cancer Patients Treated with Interleukin-2
1992 • 40 citations
Exploring How to Get at--and Eradicate--Hidden HIV
1998 • 39 citations
Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens
1998 • 36 citations
Treatment of malignant melanoma and renal cell carcinoma with recombinant human interleukin-2: analysis of cytokine levels in sera and culture supernatants
1992 • 28 citations
Comparison between subcutaneous and intravenous interleukin‐2 treatment in HIV disease
1998 • 24 citations
A National Tissue Bank to Track HIV Eradication and Immune Reconstitution
1998 • 12 citations
Clinical trial of natural human lymphocyte-derived interleukin 2 in cancer patients: Effects on cytokine production and suppressor cell status
1991 • 2 citations